Identification of Positive and Negative Regulatory Regions Controlling Expression of the Cartilage Matrix Protein Gene by Kiss, Ibolya et al.
Vol. 10, No. 5MOLECULAR AND CELLULAR BIOLOGY, May 1990, p. 2432-2436
0270-7306/90/052432-05$02.00/0
Copyright C 1990, American Society for Microbiology
Identification of Positive and Negative Regulatory Regions
Controlling Expression of the Cartilage Matrix Protein Gene
IBOLYA KISS,'* ZSUZSA BOSZE,2t PIROSKA SZABO,' RENCENDORJ ALTANCHIMEG,lt
ENDRE BARTA,'t AND FERENC DEAKl
Institute of Biochemistry' and Institute of Genetics,2 Biological Research Center of the
Hungarian Academy of Sciences, P.O. Box 521, H-6701 Szeged, Hungary
Received 16 November 1989/Accepted 1 February 1990
A complex pattern of regulation of the cartilage matrix protein gene was revealed by transient expression
experiments. A minimal promoter from positions -15 to +64 functioned in chondrocytes and fibroblasts. An
enhancer located in the first intron exerted chondrocyte-specific stimulation on the minimal promoter activity.
The same fragment, however, had a negative effect in fibroblasts. Between -334 and -15, a silencer was found
which inhibited the gene expression driven from its homologous as well as heterologous promoters both in
chondrocytes and fibroblasts. Additional positive and negative control regions were mapped further upstream
of the promoter.
Cartilage plays an important role in vertebrate develop-
ment. Chondrocytes, the cellular components of cartilage,
secrete a characteristic set of macromolecules (11). Genes
for cartilage proteins are activated in a sequential order
concomitant with chondrogenesis (6, 18, 24), indicating the
role of both common and distinct regulatory elements in
their control. Data are available concerning only the regula-
tion of the type II collagen gene (12, 19). In an attempt to
investigate the molecular events underlying the cartilage-
specific gene expression, we isolated genes for chicken link
protein (17) and cartilage matrix protein (CMP) (16).
CMP is a major noncollagenous glycoprotein of hyalin
cartilage that forms oligomers via disulfide bridges and may
have a function in matrix assembly (1, 22). The monomer of
chicken CMP has a molecular weight of 54,000. The protein
consists of two repeated I domains connected by an EGF
module, indicating a common evolutionary origin with vari-
ous protein families (1, 15, 16, 23).
We have located recently the putative promoter of the
CMP gene (16). To identify cis-acting regulatory regions,
selected fragments from the 5' end and the first intron of the
gene were coupled to the chloramphenicol acetyltransferase
(CAT) reporter gene driven from homologous as well as
heterologous promoters. In the names of the constructs, +
and - indicate whether the fragment was inserted in the
direct or opposite orientation, respectively, relative to the
CAT gene. All positions are given in base pairs from the first
T of the TATA motif of the CMP gene. Primary chondro-
cytes were obtained from sterna of 14-day-old chicken
embryos. Parallel plates of chondrocyte and fibroblast cul-
tures were transfected with the recombinant clones by the
calcium phosphate method (10) and assayed for CAT activity
(9). To correct for the transfection efficiency, parallel plates
were also transfected with a control plasmid. The results are
expressed as a percentage of the value of CAT activity
obtained with the control plasmid (relative CAT activity).
Far-upstream negative regulatory region. The 5'-flanking
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fragments of the CMP gene were inserted into the Hindlll
site of pTK. CAT (21). From -10.7 to -2.4 kilobases (kb),
no enhancer which was able to increase the expression of the
CAT gene driven from the heterologous thymidine kinase
(TK) promoter was found (Table 1). Insertion of HA and HB
fragments, however, decreased the promoter activity in
chondrocytes by 10- and 5-fold, respectively, in either ori-
entation. The observation that only a moderate inhibition
was detected in fibroblasts indicates the presence of chon-
drocyte-specific negative regulatory elements from 6.8 to
10.7 kb upstream of the CMP gene.
Enhancer activity in the first intron. When the 1.2-kb
BglII-NcoI fragment carrying the CMP promoter was fused
to the CAT reporter gene (Fig. 1), very low activity was
monitored upon transfection of chondrocytes with the pa-
rental plasmid pCMP. CAT. N (Fig. 2). The CAT synthesis
decreased even further when fragment B was deleted
[pCMP- CAT. N(-B)]. The reason for the weak CMP
promoter activity could be either the lack of a tissue-specific
enhancer or the presence of a negative regulatory element in
the 5'-flanking region of the gene.
In an attempt to find a transcriptional enhancer, we
inserted Pa, Pb, Pc, and additional overlapping fragments
from the first intron into the CMP promoter-CAT constructs
5' of the promoter. The effect of the Pc fragment (+966 to
about +3000) was rather inhibitory. Among the fragments
tested, inclusion of the Pb fragment (+578 to +966) into
pCMP- CAT. N(-B) resulted in the highest activity, cor-
responding to 10- to 12-fold stimulation in chondrocytes
(Fig. 2). The enhancement was specific for chondrocytes,
resulting in only a moderate increase in fibroblasts. The fact
that the fragment was able to exert significant stimulation on
the promoter activity in both orientations and in a configura-
tion different from the natural one indicates the presence of
enhancerlike elements between +578 and +966. Further-
more, sequence analysis revealed the presence of an en-
hancer core (14) sequence motif in the fragment.
Deletion analysis. Insertion of the Rous sarcoma virus
enhancer (20) into the SalI site of the parental plasmid in
either orientation was not able to stimulate the CMP pro-
moter activity more than twofold (data not shown), suggest-















TABLE 1. Modulation of CAT activity by 5'-flanking HindIII
fragments of the CMP gene when transcribed from
the heterologous TK promoter
Relative CAT activity
Frag- Positiona Orientation in (% ± SD)' in:
ment pTK CAT
Chondrocytes Fibroblasts
HA -10.7 to -8.0 Direct 13.7 ± 0.8 64.9 ± 14.7
Opposite 11.8 ± 4 46.4 ± 24.7
HB -8.0 to -6.8 Direct 14.3 ± 5.1 62.8 ± 9.7
Opposite 21.7 ± 5.4 42.2 ± 9.7
HC -6.8 to -5.8 Direct 76.8 ± 18.9 102 ± 11.6
HD -5.8 to -2.4 Direct 74.5 ± 22.9 56.4 + 0.7
a In kilobases from the TATA box of the CMP gene.
b Each value represents the mean from three to six independent transient
transfection experiments and is expressed relative to the activity of control
plasmid pTK- CAT (100%), which corresponds to 30 to 50%o chloramphenicol
acetylation.
To locate the negative regulatory region, fragments A, B,
and C spanning the 5'-flanking region of the CMP gene from
positions -1136 to -942, -942 to -334, and -334 to -15,
respectively, were removed in different combinations from
the parental plasmid (Fig. 3). Figure 4 summarizes the effects
of the deletions on gene expression in the absence and
presence of the enhancerlike Pb fragment. Removal of all
three fragments, resulting in pCMP- CAT. N(-ABC), in-
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creased the level of expression compared with that of the
parental plasmid. Therefore, we concluded that sequences
between -15 and +64 were sufficient to function as a
minimal promoter.
In chondrocytes, deletion of fragment C yielded an eight-
fold increase in CAT activity [compare pCMP- CAT. N(-C)
with the parental plasmid]. Even constructs carrying the
minimal promoter showed 3- to 12-fold higher levels ofCAT
synthesis than either of the constructs containing fragment
C. The data indicate, therefore, that fragment C harbors a
strong negative regulatory element(s).
The presence of fragments A and B stimulated the minimal
promoter activity about 2.5-fold in chondrocytes [compare
pCMP. CAT. N(-C) with pCMP- CAT. N(-ABC) in
Fig. 4]. It demonstrates that an upstream positive control
region located between -1136 and -334 contributes to the
CMP promoter activity.
The intronic Pb fragment, referred to as enhancer in Fig. 3
and 4, was introduced 5' of the CMP promoter into the
members of the deletion series. The construct harboring the
enhancer fragment and the minimal promoter gave rise to the
highest level of gene expression among the CMP-CAT
derivatives in chondrocytes (Fig. 4). The promoter activity
increased up to about 24% of that measured for pSV2- CAT,
which carries the strong simian virus 40 enhancer. This
finding shows that the stimulation achieved by sequences
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FIG. 1. Construction of the CMP promoter-CAT plasmid. The BamHI-XhoI fragment of pTK. CAT (21) carrying the TK promoter was
replaced by the 1.2-kb BgIII-NcoI fragment of subclone pgCMP107/112 after nuclease S1 treatment of the NcoI and XhoI ends. Relevant
restriction sites are indicated. Sequence analysis revealed that pCMP. CAT. N carried the CMP promoter region from positions -1136 to
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FIG. 2. Modulation of CAT activity by intronic fragments. Con-
struct pCMP. CAT. N(-B) was generated by deleting the Sacl
fragment (-942 to -334, fragment B in Fig. 3) from the parental
plasmid. Pa (+224 to +557) and Pb (+578 to +966) fragments were
inserted in both orientations into the PstI site of this plasmid.
Cultures of 7.5 x 106 to 1 x 107 chondrocytes or 5 x 106 to 7 x 106
fibroblasts were transfected with 10 ,ug ofDNA 3 to 4 h after plating.
CAT activity values obtained for each DNA from duplicate or
triplicate plates were averaged. Relative CAT activity was calcu-
lated after the activity of the pSV2 CAT (9) control was defined as
100lo. The histogram represents the averages ± standard deviation
determined from seven and five independent transfection experi-
ments in chondrocytes (O) and fibroblasts (E), respectively.
located in the intronic Pb fragment is within the range of
effects of the viral enhancers.
The enhancer element also increased the level of gene
expression when fragment B was removed from the parental
plasmid [Fig. 4, derivative (-B)], but in the presence of
fragment B, it was rather inhibitory. This suggests further
interactions between the intronic and upstream regulatory
elements.
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FIG. 3. Structure of CMP promoter-CAT plasmids containing
deletions in the 5'-flanking control region. Relevant restriction sites
utilized for construction of the plasmids are indicated. SalI and AvaI
ends were ligated directly, while T4 DNA polymerase treatment was
used before joining SacI and AvaI as well as SalI and Sacl ends to
each other. The sizes and positions of deletions are represented by
dotted lines. The box labeled PstI b corresponds to the intronic Pb
fragment, which carries enhancerlike activity. This fragment was
inserted into one set of the constructs at the PstI site.
rat hepatoma cells were also transfected with the constructs.
It is interesting to note that the CMP minimal promoter was
about fourfold more active in fibroblasts than in chondro-
cytes (Fig. 4). pCMP- CAT. N(-C) displayed the highest
level of CAT synthesis in fibroblasts. The 26-fold increase in
activity upon removal of fragment C from the parental
plasmid indicates that the negative control elements located
in fragment C can inhibit the CMP promoter activity even
more drastically in fibroblasts than in chondrocytes.
Each of the constructs harboring the enhancer fragment
yielded a low level of CAT activity in fibroblasts, and only a
slight increase was observed upon insertion of the pb frag-
ment into pCMP- CAT N(-B). To sum up, the Pb frag-
ment conferred positive regulation to the minimal promoter
in chondrocytes, while in fibroblasts it repressed the gene
expression more than threefold.
None of the constructs depicted in Fig. 3 was active in the
Reuber-H56 rat hepatoma cell line (5, 25), giving relative
CAT activity values below 2% in several independent exper-
iments (data not shown).
Our data demonstrate that both the CMP promoter and the
enhancer work in a tissue-specific manner. The minimal
promoter is active in other connective tissue cells, such as
fibroblasts, but not in cells of different origins. The enhancer
fragment, however, functions only in chondrocytes and
plays an important role in conferring chondrocyte-specific
expression to the CMP gene. It may carry binding sites for
both positive and negative factors, and the net effect de-
pends on the actual concentrations of the different factors in
a given tissue. The close proximity of positive and negative
regulatory regions was reported for other genes (7, 13, 26).
Fragment C acts as a silencer. To test whether the negative
element located immediately upstream of the CMP promoter
is capable of reducing the activity of heterologous promot-
ers, we inserted fragment C into pTK. CAT at various
positions both 5' and 3' of the reporter gene. Each construct
displayed a markedly repressed CAT synthesis in either
orientation compared with that of pTK. CAT, indicating
that the fragment exerted a negative regulation on the TK
promoter at all positions tested (Fig. 5). Therefore, we
concluded that the fragment carries a silencer.
The levels of inhibition varied in the given constructs.
When inserted in the opposite orientation, fragment C re-
pressed the TK promoter activity by factors of 10 to 65.
Upon insertion in the direct orientation, the reduction was
33-fold at position +1783 and less pronounced (3-fold) at
positions -223 and -326 [compare derivative Pv2(+) with
P19(+) and Pvl(+) in Fig. 5]. Further studies are necessary
to understand the molecular basis of differences in the
silencer activity observed when placed 5' of the promoter.
Either the distance from the TK promoter or the nucleotide
sequences surrounding the site of insertion may influence the
silencing effect via protein-mediated interactions [compare
derivative B9(+) with P19(+) and Pvl(+) in Fig. 5]. Nucle-
ase S1 analysis confirmed that insertion of fragment C did
not change the initiation site of transcription and that inhi-
bition occurred at the level of transcription (data not shown).
Negative regulation was not restricted to chondrocytes.
Similar repression was observed in fibroblasts (data not
shown).
Fragment C was also inserted into pRSV CAT (8) at the
SphI site located between the Rous sarcoma virus enhancer
and promoter. Compared with that measured in
pRSV CAT, the relative CAT activity values measured in
chondrocytes in the direct and opposite orientations dropped
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FIG. 4. Effect of removal of 5'-flanking sequences on CMP promoter activity. Roman numerals designate the constructs as in Fig. 3, and
the fragments deleted are indicated to the right of each graph. The histogram summarizes the results of four to nine independent transfection
experiments. The relative CAT activity is given as percentage of the pSV2 CAT control. Symbols: * and a, with and without the enhancer
(the intronic Pb fragment of the CMP gene), respectively. nd, Not determined.
This observation demonstrates that the silencer is able to
interfere with the Rous sarcoma virus enhancer and that the
repression is also more pronounced in the opposite than in
the direct orientation.
The results reported here identify several blocks of control
elements dispersed at the 5' end and in the first intron of the
chicken CMP gene which modulate the activity of the
minimal promoter. Stimulation was achieved by a region
from -1136 to -334 and by a cartilage-specific enhancer
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FIG. 5. Inhibition of TK promoter activity by fragment C carry-
ing the negative CMP control element. The numbers above the
graph indicate the positions where fragment C was inserted into the
pTK. CAT vector (+ 1 corresponds to the translation initiation site
of the TK gene). In the names of the constructs, insertion sites are
denoted as follows: B, BamHI; P, PstI; Pv, PvuII; S, Sall. The ends
of fragment C and the Sall and PstI ends were treated with T4 DNA
polymerase. BamHI ends were polished with nuclease S1. Clones
were verified by sequence analysis. In B4(-), 3 nucleotides were
removed 3' of the BamHI cleavage site, while in B9(+), 6 and 9
nucleotides were removed from the vectors upstream and down-
stream, respectively. Results of four independent transfection ex-
periments in chondrocytes using pTK CAT control are shown.
enhancer in the first intron is also characteristic for the type
II collagen and other procollagen genes (12; for a review, see
reference 3). The silencer fragment located immediately
upstream of the TATA signal inhibited the promoter activity
in both chondrocytes and fibroblasts. This finding suggests
that the negative factors which bind to the silencer are also
present in chondrocytes of 14-day-old chicken embryos.
Similarly to the CMP silencer, the r-globin silencer also
inhibits its own promoter at the natural position both in
erythroid and nonerythroid cell lines (4).
When the CMP enhancer was inserted upstream of the
1.2-kb CMP promoter fragment, it was not able to override
the inhibition caused by the silencer region unless fragment
B was deleted (Fig. 5). One explanation could be that
additional, more remote enhancer sequences are also in-
volved in transcriptional control of the gene. Alternatively,
disruption of the natural organization of the regulatory
elements in the constructs may alter the interactions of these
elements with the promoter and with one another, resulting
in a low level of gene expression. It has been reported that
regulation of human al(I) collagen gene is highly influenced
by the geometry of the control elements around the tran-
scriptional start site via protein-mediated promoter-intron
interactions (2).
It is also possible that the CMP promoter or enhancer or
both display the highest activity when the gene is turned on
in the prechondrogenic limb mesenchymal cells (1, 24), since
the biosynthesis of CMP seems to be suppressed later during
differentiation (6). A correlation between chondrogenesis
and the enhancer activity of the rat type II collagen gene was
published recently (12).
The experiments described in this paper provide a basis
for the further characterization of the CMP regulatory ele-
ments and can promote identification of transacting factors
involved in the regulation of cartilage-specific genes.
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